Clinical Trial Update: A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating changes in nasal airflow after allergen exposure for loratadine/pseudoephedrine tablet and fluticasone propionate nasal spray in allerg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Fluticasone Propionate Nasal Spray (Fluticasone propionate nasal spray)
• Loratadine/Pseudoephedrine Tablet (loratadine/pseudoephedrine)

Snippet

Sponsor: Bayer | Conditions: Rhinitis, Allergic | Phase 4 | Status: COMPLETED